COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 11:12, il y a 2 mois 11 jours EQS-Adhoc: Redcare Pharmacy N.V.: Change in the Managing Board; Peter Schmid von Linstow to become Chief Executive Officer. Redcare Pharmacy N.V. appoints Peter Schmid von Linstow as new CEO, replacing Olaf Heinrich. Heinrich to stay on in advisory role. Announcement made by Supervisory Board CEO Appointment Supervisory Board Redcare Pharmacy N.V. Executive Board Change Advisory Role
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 11:00, il y a 2 mois 11 jours Warren Wise Unravels the Rheinmetall Paradox – Defense Boom Without a Share Price Rally Warren Wise investigates Rheinmetall's defense boom but falling share price, analyzing company's economic moat, transparency, and valuation factors. Podcast available at warren-wise.com Share Price Rheinmetall Warren Wise Economic Moat Defense Boom
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 10:58, il y a 2 mois 11 jours High approval at the Annual General Meeting – Shareholders confirm the course of Netfonds AG High approval at the Annual General Meeting as Netfonds AG shareholders confirm company course. Detailed financial year report presented by CEO and CFO Annual General Meeting Shareholders Netfonds AG Financial Industry Approval
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 10:55, il y a 2 mois 11 jours Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates Heidelberg Pharma and Huadong Medicine sign new collaboration agreement to jointly develop Antibody Drug Conjugates, expanding pipeline with innovative products Heidelberg Pharma ADC Technology Antibody Drug Conjugates Collaboration Agreement Huadong Medicine
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 10:48, il y a 2 mois 11 jours EQS-Adhoc: Heidelberg Pharma and Huadong Medicine Sign Additional Collaboration Agreement to Jointly Develop New Antibody Drug Conjugates Heidelberg Pharma and Huadong Medicine sign a new collaboration agreement to jointly develop new Antibody Drug Conjugates, broadening their existing partnership and combining proprietary technologies Heidelberg Pharma ADC Technology Antibody Drug Conjugates Collaboration Agreement Huadong Medicine
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 10:39, il y a 2 mois 11 jours Eramet : Bilan semestriel du contrat de liquidité au 30 juin 2026 ERAMET publie son bilan semestriel de contrat de liquidité pour le 1er semestre 2026, avec détails des transactions d'achat et de vente de titres Contrat De Liquidité Bilan Semestriel Transactions Titres Eramet
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 10:10, il y a 2 mois 11 jours XCMG Unveils World's First 14,000-Ton Ring Crane, Redefining Ultra-Heavy Lifting XCMG unveils the world's first 14,000-ton ring crane, revolutionizing ultra-heavy lifting with innovative technology and energy-saving features Innovation Energy-saving Ultra-heavy Lifting 14,000-ton Ring Crane XCMG
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 10:06, il y a 2 mois 11 jours PLAN-B NET ZERO scales technology platform with additional PaaS customer PLAN-B NET ZERO expands technology platform with new PaaS customer, driving scaling of neo-energy model. Additional connections increase platform reach and user base Technology Platform Scalability PLAN-B NET ZERO PaaS Customer Neo-energy Model
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 10:00, il y a 2 mois 11 jours iFX EXPO LATAM Evolves into The Trading Festival Mexico for 2026 Mexico City, Mexico, August 28th, 2026, FinanceWire
COMMUNIQUÉ DE PRESSE publié le 28/08/2026 à 09:49, il y a 2 mois 11 jours EQS-Adhoc: REPLOID Group AG plans to increase free float and prepares transition to the prime market segment of the Vienna Stock Exchange REPLOID Group AG plans to increase free float and transition to prime market segment of Vienna Stock Exchange in Summer 2027, boosting liquidity through capital increases and convertible bonds Capital Increase Vienna Stock Exchange Free Float REPLOID Group AG Prime Market
Publié le 09/11/2026 à 07:00, il y a 55 minutes bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Publié le 09/11/2026 à 07:00, il y a 55 minutes BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Publié le 09/11/2026 à 07:00, il y a 55 minutes Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Publié le 09/11/2026 à 07:00, il y a 55 minutes bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Publié le 06/11/2026 à 19:06, il y a 2 jours 12 heures ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Publié le 06/11/2026 à 22:15, il y a 2 jours 9 heures Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Publié le 06/11/2026 à 13:00, il y a 2 jours 18 heures Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Publié le 06/11/2026 à 12:30, il y a 2 jours 19 heures Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Publié le 06/11/2026 à 12:30, il y a 2 jours 19 heures Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Publié le 09/11/2026 à 07:30, il y a 25 minutes Hannover Re increases Group profit and confirms full-year guidance
Publié le 09/11/2026 à 07:30, il y a 25 minutes SUSS Expands Photomask Portfolio with Next-Generation ASC9500 Mid-End Cleaner
Publié le 09/11/2026 à 07:30, il y a 25 minutes GEA delivers strong third quarter: order intake rises substantially, revenue and profitability further improved
Publié le 09/11/2026 à 07:30, il y a 25 minutes Nordex Group to enter Albania with 84 MW order from Verbund
Publié le 09/11/2026 à 07:30, il y a 25 minutes q.beyond posts high volume of one-off charges in Q3 2026 – restructuring set to pay off from 2027 onwards